Every 424B that BrightSpring Health Services, Inc. (BTSG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BTSG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BTSG filings page.
BrightSpring Health Services, Inc. is registering the resale of 14,999,771 shares of common stock by selling stockholders, including KKR Phoenix Aggregator L.P. This is a resale offering and the company will not receive proceeds except for cash received from the exercise of options by management sellers.
Under the terms shown, the public offering price is $58.75 per share, resulting in proceeds to the selling stockholders of approximately $876,781,614.26. Subject to closing, the company intends to concurrently purchase 1,026,465 shares from the underwriter at the same price (the "Repurchase").
BrightSpring Health Services, Inc. filed a preliminary prospectus supplement registering for resale an aggregate of 15,000,000 shares of its common stock by selling stockholders, including KKR Phoenix Aggregator L.P. The company will not receive proceeds from the resale except for proceeds from cash exercises of options by management selling stockholders.
Subject to closing of the offering, BrightSpring intends to concurrently repurchase, from the underwriter out of the 15,000,000-share block, up to the lesser of $60 million and 10% of the aggregate size of the offering; the repurchase price per share will equal the underwriter purchase price. The filing states 197,284,877 shares outstanding as of June 2, 2026, a June 2, 2026 Nasdaq closing price of $59.34, and several equity-related context items including options, RSUs, plan reserve and tangible equity units.
BrightSpring Health Services resale prospectus: the selling stockholders are offering 20,000,000 shares of common stock. The company will not receive proceeds from the resale other than proceeds from cash exercise of management options. The prospectus shows a public offering price of $41.15 per share and aggregate proceeds to the selling stockholders of approximately $819,220,000. Subject to the closing of the offering, BrightSpring intends to purchase concurrently 1,464,807 shares from the underwriter and cancel them; the Repurchase is contingent on the offering closing. Shares outstanding were 193,549,161 as of February 27, 2026; the document also reports an expected post-offering outstanding share count of 192,369,354 as of February 27, 2026 after giving effect to the Repurchase and certain option exercises.
BrightSpring Health Services, Inc. is registering 20,000,000 shares of common stock for resale by selling stockholders, including KKR Phoenix Aggregator L.P., pursuant to a preliminary prospectus supplement dated March 2, 2026. The company will not receive proceeds from these resales except for proceeds from the cash exercise of stock options by management selling stockholders.
The prospectus supplement states that, subject to closing this offering, BrightSpring intends to concurrently repurchase up to the lesser of $60 million and 10% of the aggregate size of the offering, with the repurchase price per share equal to the underwriter’s purchase price. The filing cites a closing sale price of $41.43 per share on February 27, 2026. Shares outstanding are listed as 193,549,161 prior to the offering and 192,385,936 after the offering and the Repurchase under the filing’s stated assumptions.
BrightSpring Health Services, Inc. is registering the resale of 15,000,000 shares of common stock by selling stockholders under a prospectus supplement filed pursuant to Rule 424(b)(7). The company will not receive proceeds from these sales, other than cash received from management stockholders’ option exercises made in connection with the offering.
The underwriter agreed to purchase at $28.7820 per share, resulting in total proceeds to selling stockholders of $431,730,000 before expenses. Subject to the offering’s completion, BrightSpring intends to concurrently repurchase 1,500,000 of these shares from the underwriter at the same price, fund the repurchase with cash on hand, and cancel the shares; the offering is not conditioned on the repurchase.
BTSG is listed on Nasdaq; the shares closed at $30.47 on October 20, 2025. Shares outstanding were 181,045,317 as of October 17, 2025; after the offering and repurchase, shares outstanding would be 179,800,317 after giving effect to 255,000 option exercises.
Preliminary Q3 2025 results (continuing ops): revenue $3,334 million (+28%), net income $37.5 million, and Adjusted EBITDA $160 million (+37%).
BrightSpring Health Services filed a resale prospectus for 15,000,000 shares of common stock offered by selling stockholders. The company will not receive proceeds from these sales, other than cash from option exercises by management selling stockholders.
Subject to completion of the offering, BrightSpring intends a concurrent stock repurchase of up to the lesser of $50 million or 10% of the offering, with repurchased shares to be cancelled. Shares outstanding were 181,045,317 as of October 17, 2025. Following the offering and the repurchase, shares outstanding would be 179,800,317 assuming a repurchase price of $29.73 and issuance of 255,000 option shares.
Preliminary Q3 2025 results show total revenue of $3,334 million (up 28.2% year over year), gross profit of $392 million (up 21.3%), net income of $37.5 million (vs. a $25.7 million loss), and Adjusted EBITDA $160 million (up 37.2%). As of September 30, 2025, cash and cash equivalents were $140.3 million, total debt was approximately $2.6 billion, and leverage under credit agreements was 3.31x.